Funder
U.S. National Institutes of Health
Washington University
MD Anderson Cancer Center Inter-Institutional Molecular Imaging Center
Anderson’s Cancer Center
Anderson Cancer Center Institutional Research
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference55 articles.
1. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma;Morris;Science,1994
2. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007
3. Anaplastic lymphoma kinase: signalling in development and disease;Palmer;Biochem. J.,2009
4. Targeting oncogenic ALK: a promising strategy for cancer treatment;Grande;Mol. Cancer Ther.,2011
5. Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal–epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK);Cui;J. Med. Chem.,2011
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献